WO1995032292A3 - Detection of viral antigens coded by reverse-reading frames - Google Patents
Detection of viral antigens coded by reverse-reading frames Download PDFInfo
- Publication number
- WO1995032292A3 WO1995032292A3 PCT/US1995/006266 US9506266W WO9532292A3 WO 1995032292 A3 WO1995032292 A3 WO 1995032292A3 US 9506266 W US9506266 W US 9506266W WO 9532292 A3 WO9532292 A3 WO 9532292A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reading frames
- polypeptide antigens
- reverse
- coded
- detection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25941/95A AU2594195A (en) | 1994-05-20 | 1995-05-17 | Detection of viral antigens coded by reverse-reading frames |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24698594A | 1994-05-20 | 1994-05-20 | |
US08/246,985 | 1994-05-20 | ||
US28556194A | 1994-08-03 | 1994-08-03 | |
US08/285,561 | 1994-08-03 | ||
US32972994A | 1994-10-26 | 1994-10-26 | |
US08/329,729 | 1994-10-26 | ||
US34427194A | 1994-11-23 | 1994-11-23 | |
US08/344,271 | 1994-11-23 | ||
US35750994A | 1994-12-16 | 1994-12-16 | |
US08/357,509 | 1994-12-16 | ||
US38988695A | 1995-02-15 | 1995-02-15 | |
US08/389,886 | 1995-02-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1995032292A2 WO1995032292A2 (en) | 1995-11-30 |
WO1995032292A3 true WO1995032292A3 (en) | 1996-01-25 |
Family
ID=27559345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/006266 WO1995032292A2 (en) | 1994-05-20 | 1995-05-17 | Detection of viral antigens coded by reverse-reading frames |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2594195A (en) |
WO (1) | WO1995032292A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6720166B2 (en) | 1994-02-14 | 2004-04-13 | Abbott Laboratories | Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use |
US6051374A (en) * | 1994-02-14 | 2000-04-18 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US6558898B1 (en) | 1994-02-14 | 2003-05-06 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US6156495A (en) * | 1994-02-14 | 2000-12-05 | Abbott Laboratories | Hepatitis GB virus recombinant proteins and uses thereof |
US6451578B1 (en) | 1994-02-14 | 2002-09-17 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US5981172A (en) * | 1994-02-14 | 1999-11-09 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use |
US5843450A (en) * | 1994-02-14 | 1998-12-01 | Abbott Laboratories | Hepatitis GB Virus synthetic peptides and uses thereof |
US6586568B1 (en) | 1994-02-14 | 2003-07-01 | Abbott Laboratories | Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
US5709997A (en) * | 1995-08-14 | 1998-01-20 | Abbott Laboratories | Nucleic acid detection of hepatitis GB virus |
US5955318A (en) * | 1995-08-14 | 1999-09-21 | Abbott Laboratories | Reagents and methods useful for controlling the translation of hepatitis GBV proteins |
US5807670A (en) * | 1995-08-14 | 1998-09-15 | Abbott Laboratories | Detection of hepatitis GB virus genotypes |
IT1284630B1 (en) * | 1996-04-17 | 1998-05-21 | Sorin Biomedica Diagnostics Sp | SPECIFIC EPITOPES OF VIRUSES ASSOCIATED WITH NON"A"-NON"E HEPATITIS, COMPOSITIONS AND METHOD FOR DETECTING ANTIBODY OF THESE EPITOPES. |
US6020195A (en) * | 1996-09-18 | 2000-02-01 | Roche Diagnostics Gmbh | Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
CN1058751C (en) * | 1998-06-15 | 2000-11-22 | 中国人民解放军第二军医大学 | Full length CDNA clone of hepatitis virus G genome and its construction method |
-
1995
- 1995-05-17 AU AU25941/95A patent/AU2594195A/en not_active Abandoned
- 1995-05-17 WO PCT/US1995/006266 patent/WO1995032292A2/en active Search and Examination
Non-Patent Citations (9)
Also Published As
Publication number | Publication date |
---|---|
AU2594195A (en) | 1995-12-18 |
WO1995032292A2 (en) | 1995-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2277362T5 (en) | Streptococcus pneumoniae antigens and vaccines | |
WO1995032292A3 (en) | Detection of viral antigens coded by reverse-reading frames | |
WO1995018826A3 (en) | Purified primate ctla-8 antigens and related reagents | |
WO1991015516A3 (en) | Hepatitis c virus epitopes | |
UA42668C2 (en) | POLYPEPTIDE, WHICH HAS THE ANTIGENIC PROPERTIES OF THE VIRUS OF HEPATITE S (HCV) (VARIANTS), DIAGNOSTIC REAGENT DL4 To THE VIRUS OF HEPATITE S (VARIANTS), COLLECTION FOR THE DEVELOPMENT OF ANTIBODIES To THE VIRUS OF HEPATITE S (VARIANTS), METHOD OF THE DEVELOPMENT OF ANTIBODIES To THE VIRUS OF HEPATITE S (VARIANTS) | |
CA2162132A1 (en) | Hepatitis b virus mutants, reagents and methods for detection | |
DE69632536D1 (en) | VACCINALS FOR THE RESPIRATORY SYNCYTIAL VIRUS WITH NUCLEIC ACIDS | |
WO1993001210A3 (en) | Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
AU571128B2 (en) | Expression of immunologically reactive aids viral protein | |
CA2057052A1 (en) | Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof | |
EP0769696A3 (en) | Antibodies and proteins useful for assaying virus infection in grape plants | |
WO1996038474A3 (en) | Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide | |
CA2071016A1 (en) | Method for detecting bovine diarrhoea virus infection nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto | |
EP0248534A3 (en) | Method of detecting aids virus infection | |
CA2098253A1 (en) | Method for producing ectoprotein of hepatitis c virus | |
EP0967223A3 (en) | Hepatitis C virus peptide antigens and a method of testing for the hepatitis C virus (HCV) | |
DE68928933T2 (en) | FIBER HEMAGGLUTININE BY B. PERTUSSIS | |
CA2080213A1 (en) | Diagnostic reagent for hepatitis c | |
DE69028561D1 (en) | Immunoassay for the detection of antibodies against HIV | |
EP1878805A3 (en) | Synthetic antigen for the detection of antibodies immunoreactive with HIV virus | |
CA2286399A1 (en) | Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines | |
CA2313609A1 (en) | Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease | |
RU98119633A (en) | A METHOD FOR OBTAINING POLYPEPTIDE OWNING ANTIGEN ACTIVITY OF THE HEPATITIS VIRUS E. A SET FOR DETERMINING ANTIBODIES TO THE CAPSER OF HEPATITIS E - HEPATITIS E VIRUS | |
DE69331796T2 (en) | Core antigen protein of the hepatitis C virus, as well as diagnostic procedure and set of reagents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA US US US US US US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA US US US US US US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |